Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment ...

Merck and the Mectizan Donation Program Donate $1 Million to the END Fund for Efforts to Help Eliminate River Blindness in Africa Since 1987 Merck Has Donated More than Two Billion Treatments of ...

Submitted by Merck & Co., Inc. Public health officials at the 20th Inter-American Conference on Onchocerciasis in Antigua, Guatemala, confirmed that more than one-third of all Latin Americans who ran ...

William C. Campbell, a former Merck researcher who continued his work at Drew University, has been awarded the 2015 Nobel Prize for Physiology or Medicine for his work combatting parasitic infections.

River blindness should be relatively easy to control. Onchocerciasis experts say tremendous strides have been made in the fight against the disease and that the battle eventually will be won.

The machete blades turned red with heat in the fire that the rubber workers built on a Liberia plantation, Thomas Unnasch remembers from a visit in the 1980s.

This year's medicine prize surprisingly goes to scientists who discovered drugs for parasitic infections causing elephantiasis, river blindness, and malaria.

In 1978 Merck scientist Dr. William Campbell suggested that the medicine MECTIZAN discovered within Merck’s laboratories could be useful against river blindness in humans.

The machete blades turned red with heat in the fire that the rubber workers built on a Liberia plantation, Thomas Unnasch remembers from a visit in the 1980s.